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ABSTRACT: The effects of malaria and HIV infection on birth weight were assessed among 300
women  in  childbirth  in  Southeastern  Nigeria  using  standard  techniques.  Prevalence  of  maternal
Plasmodium  falciparum malaria  infection  was  16.0%.  Individuals  of  younger  age,  primigravidae,
anemic (with Hgb <11.0g/dl) and those who had never attended antenatal clinic (ANC) were more likely
to  have  malaria  infection.  Prevalence  of  HIV  infection  was  3.6%  and  malaria  prevalence  was
significantly higher among HIV-positive than HIV-negative women (37.5%, 95% CI, 4.0-71.0% versus
14.3%, 95% CI., 9.6-19.0%), (ˇ2 =13.3, P<0.05). Malaria-infected women had a significantly higher
proportion of lBW babies than the uninfected (F-ratio=15.05, P<0.05). A higher proportion of low birth
weight (lBW) was recorded among  anemic women, primigravidae and those who never attended ANC.
lBW  babies  were  significantly  higher  among  HIV-positive  than  HIV-negative  women  (25.0%  vs
16.6%), (F-ratio=130.8, P<0.05).  Malaria and HIV interventions via ANC are crucial for reduction of
their adverse effects on pregnancy outcome.
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INTRODUCTION
Malaria, caused by the human Plasmodium parasites
infection, and Acquired Immunodeficiency Syndrome
(AIDS) constitute severe health problems in many parts
of  the  world.  The  combination  of  malaria  and  HIV
infection result in more than 4 million deaths per year,
with the greatest impact in Africa, India, Southeast Asia,
and  South  America  (1,2).  Malaria,  which  has  been
described  as  the  disease  of  poverty  and
underdevelopment, is considered the most complex and
overwhelming health challenge facing humanity in the
vast  majority  of  developing  tropical  and  sub-tropical
countries,  with  300  to  500  million  cases  and  2  to  3
million deaths per year (3). Sub-Saharan Africa remains
the most malaria-affected region with about 90% of all
malaria  deaths  in  the  world  today,  largely  due  to
Plasmodium  falciparum.  The  most  dangerous  of  the
four human malaria parasites, it causes the majority of
infections and accounts for an estimated 1.4 and 2.6
million deaths per year in this region (4,5). In addition,
the  most  effective  malaria  vector,  the  mosquito
Anopheles  gambiae,  is  widespread  in  the  region  and
difficult to control (5). 
Sub-Saharan Africa remains by far the most-affected
region  of  the  global  HIV/AIDS  epidemic,  with  25.4
million  people  living  with  HIV,  64%  of  the  world’s
affected population (6). In this region, females are the
more severely affected with women of reproductive age
making up almost 57% of adults living with HIV, and
accounting for up to 80% of the world’s HIV-infected
women  (7,8).    In  sub-Saharan  Africa  the  HIV  and
malaria epidemics do overlap with severe public health
consequences  particularly  among  women  of  child
bearing age. Each year in the sub-region, approximately
25  million  women  become  pregnant  and  are  at
increased risk of infection by Plasmodium falciparum
(9). Also the HIV prevalence rate has sometimes been
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reported as exceeding 40% among pregnant women in
the  sub-region  (10).  It  is  therefore  estimated  that
approximately  one  million  pregnancies  per  year  are
complicated by co-infection with malaria and HIV in
sub-Saharan  Africa  (11).  This  is  because  the  two
diseases are known to critically intersect in pregnancy
and  have  serious  consequences  in  pregnant  women,
fetuses,  and  infants  (12,13).  Both  malaria  and  HIV
infection  have  potentially  severe  effects  on  pregnant
women  and  on  the  outcome  of  pregnancy,  with  each
infection  contributing  adverse  outcomes  of  low  birth
weight  (LBW)  through  prematurity  or  intrauterine
growth  retardation  (IUGR),  known  to  be  the  single
greatest risk factor for neonatal and infant mortality (14).
Studies  from  sub-Saharan Africa  have  showed  that
infant mortality is three times higher for LBW babies
than for those of normal weight (15). The effects on
neonatal mortality are even more marked; a LBW baby
being nine times more likely to die in the first month of
life than a normal-weight baby (16). The mechanisms
by which either malaria or HIV infection lead to LBW
remain unclear (17-21). However, malaria is thought to
reduce birth weight through a combination of systemic
and  local  effects.  Malaria  may  affect  birth  weight
through malaria-induced anemia.  It may also reduce
birth  weight  through  placental  infection  (18).
Advanced-stage  HIV  disease,  previous  history  of
preterm  birth,  a  CD4  cell  count  <200  cells/mm,
primiparity, maternal literacy, and infant HIV infection
at birth were also significantly associated with low birth
weight (21). 
In Nigeria and other parts of West Africa with similar
settings, there is a scarcity of population-based data on
the  association  of  maternal  malaria,  anemia,  HIV
infection and birth weight. This dearth of information
has  made  the  formulation  of  policies  that  would
transform  into  effective  and  sustainable  malaria  and
HIV intervention/control programs for pregnant women
an enormous challenge. The major objectives of this
present study were two fold: 1) To provide scientific
data  on  the  contributory  role  of  maternal  malaria,
anemia and HIV infection at full pregnancy term on
neonatal  birthweight.  2)  To  provide  information  that
would have public health significance and relevance to
policy development and program implementation, as it
relates  to  the  overall  maternal,  fetal  and  infant
wellbeing  in  Nigeria  and  other  developing    nations
threatened by both malaria and HIV infection.  
MATERIAlS AND METHODS
Study Area
This study was conducted in Abakaliki, the capital of
Ebonyi State in South Eastern Nigeria, from June 2006
to  December  2006.  The  study  area  is  defined  by
longitude 8o61611E and latitude 6o2212811N, elevated
at 380ft above sea level. The characteristic vegetation is
that of the tropical rain forest with an average annual
rainfall  of  1,600mm  and  an  average  atmospheric
temperature of 30oC. There are two distinct seasons: the
wet and the dry seasons; the former takes place between
April  and  October,  while  the  latter  occurs  from
November to March. Malaria transmission in the area is
perennial but usually at the peak towards the end of the
rainy season. The study was conducted at the Ebonyi
State  University  Teaching  Hospital  (EBSUTH)  in
Abakaliki. Apart from being the largest health facility in
the  area,  EBSUTH  serves  as  a  referral  centre  for
gynecological services and runs the biggest antenatal
clinic and maternity ward in Ebonyi State.
Ethical Considerations
The study protocol was approved by the Infectious
Diseases  Research  Division  of  the  Department  of
Medical  Microbiology/Parasitology  at  Ebonyi  State
University.  Ethical  approval  was  obtained  from  the
Ethical Committee of the EBSUTH.  The approval was
on  the  agreement  that  patient  anonymity  must  be
maintained, good laboratory practice/quality control be
ensured, and that every finding would be treated with
utmost  confidentiality  and  for  the  purpose  of  this
research only. All work was performed according to the
international guidelines for human experimentation in
clinical research (22).  
Study Population/Sampling Technique
The study population comprised of 300 women at full
pregnancy  term. A  pregnant  woman  was  eligible  for
participation in the study if she attended the antenatal
clinic  at  EBSUTH  and  met  the  following  study
inclusion criteria:  (i) had an uncomplicated singleton
birth  pregnancy  >  32  weeks  gestation  (based  on  the
fundal height estimation), (ii) resided in Abakaliki or
neighboring local government areas, and (iii) had no
known underlying chronic illness. Women who did not
attend ANC at EBSUTH or any other antenatal clinic
but  met  the  other  study  inclusion  criteria  were  also
enrolled in the study.
Following informed consent, at delivery, 5ml of the
maternal  peripheral  blood  was  obtained  from  each
participant  by  venepuncture  technique  into  a  sterile
EDTA  container.    Information  was  obtained  on  the
delivery  outcome  including  baby’s  sex,  mode  of
delivery and birth weight (kg). The birth weight was
determined  using  an  electronic  weighing  machine
immediately  after  child  birth.  Information  on  the
participants’ age, parity, use of insecticide-treated bed
nets (ITNs) and frequency of antenatal clinic visits were
obtained from the case files of each individual and by
interview.44 McGill Journal of Medicine 2009
remaining  74  mothers  could  not  be  obtained  due  to
logistic problems encountered at the labor ward during
the study. The non-availability of the information was
because  maternal  blood  sample  was  collected  at  the
inception of labour after which it usually took between
30 minutes to 10 hours for actual delivery. Thus, the
nurses who were on duty at the labour ward during such
times  failed  to  record  the  birth  weight  of  some  the
babies  after  childbirth  in  the  project  data  collection
forms provided due to the following reasons; (a) they
were unaware of the research, (b) out of inadvertence,
and (c) reluctant to do "extra work".
According to investigation criterion, malaria parasites
were  found  in  the  peripheral  blood  of  48  (16.0%)
women. Of the 48 women infected by malaria parasite,
1-10 parasites per 100 thick film fields were recorded in
11 women (22.9) while 11-100 parasites per 100 thick
film fields were recorded in the remaining 37 (77.1%).
The  prevalence  of  malaria  infection  in  relation  to
maternal  age,  parity,  ANC  attendance,  and  HIV
infection among the women at childbirth is summarized
in Table 1. Individuals of age group 20-24 years had the
highest  prevalence  of  maternal  malaria  (20.8%,
Table  1:  Prevalence  of  malaria  infection  in  relation  to
demographic/obstetrics  data,  HIV  infection  and  haemoglobin
concentration among women at childbirth in Abakaliki, Nigeria.
Laboratory Analysis
Giemsa-stained  thick  and  thin  blood  films  were
performed to determine malaria infection and the Plus
System  was  used  for  the  determination  of  parasite
density as previously outlined (23). All the films were
double-checked blindly by experienced parasitologists
and if there was disagreement, an additional assessment
was made by another observer and the average of the
two  agreeing  counts  using  the  Plus  System  was
recorded. Parasitaemia was graded as 1-10 parasites per
100 thick film fields (‘+’ or 4-40 parasites per mm3),
11-100 parasites per 100 thick film fields (‘++’ or 41-
400 parasites per mm3), 1-10 parasites per single thick
film fields (‘+++’ or 400-4000 parasites per mm3).
The  hemoglobin  concentration  was  determined  to
assess  maternal  anaemia  using  the
cyanmethaemoglobin  method  described  previously
(24);  reading  was  done  using  a  spectrophotometer
(Bayer  RA  50).  The  HIV  Tri  Line  Test  kits,
commercially available (Biosystem INC, Austria) were
first used to screen each subject’s serum sample which
was separated from the blood to detect antibodies to
HIV-1  and  HIV-2.  Thereafter  the  HIV-seropositive
samples were confirmed by immunoblot analysis using
the  BIORAD  New  Lav  Blot  kits,  which  are
commercially available (Bio-Rad Novapath Diagnostic
Group US.). Manufacturer’s instructions were strictly
followed to determine the sero-status of the samples. All
the analysis was done at the Research Laboratory of
Department  of  Medical  Microbiology,  Ebonyi  State
University, Abakaliki.
Statistical Analysis
Percentage  prevalence  rates  were  calculated  with
their respective 95% confidence intervals. Difference
between  proportions  were  evaluated  using  chi-square
tests while differences in means where evaluated using
one-way  analysis  of  variance  ANOVA.  Statistical
significance were achieved at P<0.05.
RESUlTS
A total of 300 women at full pregnancy term were
studied during childbirth in this research, and of these,
278(92.7%) had spontaneous vaginal delivery (SVD),
19(6.3%) had caesarean section (CS), and 3(1.0%) had
vacuum extractor (ventouse). Information was available
on the babies born to 226 of the mothers. Of the 231
babies,  of  which  119  (51.5%)  were  males  and  112
(48.5%) were females, 219 (116 males and 103 females)
were single births, 12 were twins (3 sets of females; 3
sets of male and female), and  3 were triplets (2 males
and  1  female).  Information  on  the  babies  of  the Malaria, HIV and Birth Weight 45 Vol. 12  No. 2
95%CI.,  11.4-30.2%)  while  the  least  was  recorded
among those older than 39 years (11.1%, 95% CI, 9.4-
31.6%), but there was no significant difference in the
trend (χ2=2.02, df =4, P>0.05).  Malaria infection was
more frequent among the primigravidae (18.0%, 95%
CI,  10.0-26.0%)  than  the  multigravidae  (15.2%,
95%CI.,  10.4-20.0%)    but  there  was  no  significant
difference in the trend (χ2=0.17, df=1, P>0.05). Women
who  did  not  attend  antenatal  clinic  (ANC)  during
pregnancy and those who attended  ANC less than 5
times  were  more  likely  to  have  malaria  infection,
although the difference was not statistically significant
(χ2=3.79,  df=3,  P>0.05).  The  prevalence  of  malaria
infection  was  higher  (16.3%,  95%  CI.,  12.0-20.6%),
among individuals who did not have insecticide treated
bednets (ITNs) than among those who had (11.8%, 95%
CI, 3.5-27.1%) but the difference was not statistically
significant (χ2=1.33, df=1, P>0.05). Result showed that
the prevalence of HIV infection was 3.6% and HIV-
positive  women  had  higher  prevalence  of  malaria
infection than the HIV-negative women (37.5%, 95%
CI, 4.0-71.0% versus 14.3%, 95% CI, 9.6-19.0%), the
difference was statistically significant (χ2 =13.3, df=1,
P<0.05). The prevalence of malaria infection decreased
with increase in Hgb and the difference was statistically
significant (χ2=23.8, df=3, P<0.05) (Table 1).  
The results of the association of neonatal birth weight
with maternal malaria infection, HIV infection, parity,
and ANC  attendance  are  summarized  in  Table  2. A
higher proportion of malaria infected women (21.6%)
had babies with low birth weight compared to women
without malaria infection (18.8%). Statistical analysis
using the one-way analysis of variance ANOVA showed
a  significant  difference  in  the  trend  (F-ratio=15.05,
df1/df2=2/3,  P<0.05).  Anemic  women  (with  Hgb
<11.0g/dl) had a higher proportion of low birth weight
babies (20.0%) than the non-anemic women (16.4%)
but the difference was not statistically significant (F-
ratio=7.34, df1/df2=2/3, P>0.05). The frequency of low
birth  weight  was  higher  among  the  primigravidae
(30.8%) than among the multigravidae (13.1%), there
was no statistically significant difference in the trend
using  ANOVA  (F-ratio=0.29,  df1/df2=2/3,  P>0.05)
(Table 2). Similarly the HIV positive women had higher
proportion of  LBW babies (25.0%) compared to the
HIV  negative  women  (16.5%)  and  there  was  a
statistically  significant  difference  in  the  trend  using
ANOVA  (F-ratio=130.8,  df1/df2=2/3,  P<0.05).  The
highest  proportion  of  LBW  occurred  among  women
who never attended the ANC during pregnancy (25.0%)
and the least among those who attended up to ten times
(8.3%). Statistically, there was no significant difference
in the trend using ANOVA (F-ratio =1.05, df1/df2=2/9,
P>0.05). 
DISCUSSION
In  this  study,  a  peripheral  blood  malaria  infection
prevalence of 16.0% was obtained from the subjects at
full pregnancy term during delivery. This is comparable
to  the  malaria  prevalence  figures  obtained  among
women at delivery in various parts of the sub-Saharan
Africa.  In  southern  Ghana  a  malaria  infection
prevalence  of  19.0%  was  obtained  (25),  8.6%  in
Kampala,  Uganda  (17),  17.6%  in  Zanzibar, Tanzania
(26), and  17.3% in Maputo, Mozambique (27). As with
malaria in children, the prevalence and manifestation of
malaria in pregnancy varies with transmission intensity,
access to treatment, coverage and quality of antenatal
Table 2: Association of neonatal birthweight with maternal malaria infection, demographic/obstetrics data, HIV infection and haemoglobin
concentration among women at childbirth in Abakaliki, Nigeria.46 McGill Journal of Medicine 2009
services, and drug resistance, among others. Variations
in  these  factors  account  for  the  differences  in  the
prevalence figures obtained from various sites of the
sub-Saharan Africa. 
Individuals  of  the  ≤19  years  and  20-24  years  age
categories were more likely to be infected with malaria
than  other  age  groups  categories,  although  the
difference in the trend was not statistically significant.
This  observation  supported  previous  findings  from
eastern Sudan (28) and in Kigali, Rwanda (29) which
indicated that age was not significantly associated with
malaria  during  pregnancy.  In  contrast  however,  a
number  of  earlier  studies  reported  a  significant
association between maternal age and malaria infection
during  pregnancy  (30,31).  In  a  study  conducted  in
Blantyre,  Malawi,  after  stratifying  by  gravidity,
associations between age and parasite prevalence were
reportedly stronger than those between gravidity and
prevalence after stratifying by age (31). The reason for
the  occurrence  of  these  age-related  differences  in
malaria prevalence may probably be related to host or
environmental factors. 
The  prevalence  of  malaria  infection  was  higher
among  the  primigravidae  than  the  multigravidae,
although the difference in the trend was not statistically
significant. This finding is consistent with reports from
other  parts  of  the  sub-Saharan  Africa  which  have
consistently  indicated  that  primigravidae  are  more
susceptible to malaria infection than the multigravidae.
This is probably because immune suppression is more
marked in primigravidae and the protective immunity
acquired  through  malaria  infection  during  the  first
pregnancy,  appears  to  reduce  susceptibility  in
subsequent pregnancies (32).
The  women  with  HIV  infection  had  a  higher
prevalence of malaria infection than those without HIV
infection. Similar findings were reported in a number of
sub-Saharan African countries including Malawi (33),
Zimbabwe  (13),  Kenya  (34),  and  Rwanda  (29).  The
reason for the higher prevalence of malaria infection
among the HIV positive individuals may be due to the
impairment of the ability of pregnant women to control
P. falciparum infection, which was earlier demonstrated
(12),  and  the  interference  with  the  maintenance  of
immune  recognition  of  malaria  by  HIV  infection  in
pregnancy (34).
In this study, anemic women were more likely to have
malaria infection than non-anaemic women. This was
consistent with reports from a number of sub-Saharan
African countries which indicated that the prevalence of
anemia was consistently higher among pregnant women
infected  with  malaria  parasites  than  those  uninfected
(28,32). Individuals with no insecticide-treated bed nets
and those who never visited the ANC or attended ANC
less than 5 times during pregnancy were more likely to
have malaria infection. In Kenya (35) and Burkina Faso
(36),  similar  results  were  reported.    These  findings
underscore the importance of ANC attendance during
pregnancy.  It  has  been  demonstrated  that  substantial
reductions in maternal malaria, anemia, and LBW have
been achieved by intervention programs, including the
use  of  ITNs,  preventive  intermittent  treatment  and
chemoprophylaxis administered at the ANC (16,35,36).
Interventions also exist for maternal anemia (e.g., good
nutrition,  iron  and  folate  supplementation,  and
hookworm  treatment)  and  these  have  been  provided
through antenatal care programs.  In fact, studies from
sub-Saharan Africa have suggested that between 25%
and 90% of these adverse events might be prevented by
full  implementation  of  existing  interventions  at  the
ANC (37). 
Low  birth  weight  (LBW)  was  associated  with
maternal malaria infection and babies born by infected
mothers had a lower mean birth weight compared to the
uninfected mothers. The prevalence of LBW was higher
among  babies  born  by  primigravidae  than  the
multigravidae. This is consistent with the findings from
similar studies conducted in south-western Cameroon
(25), Zanzibar, Tanzania (26) and rural Malawi (39).
Falciparum malaria  during  pregnancy  has  long  been
recognized  as  an  important  determinant  of  low  birth
weight (40). A number of randomized controlled trials
of preventive antimalarial measures during pregnancy
have  confirmed  this  causal  effect  by  showing  that
preventing  malaria  increases  birth  weight  (41,42).
Therefore, the prevention of malaria in pregnancy, and
thus,  of  malaria-attributable  low  birth  weight  should
increase the survival of young babies.
It is already well established that the major adverse
effect of malaria in pregnancy on the mother is anemia.
In malarious areas, malaria and anemia are likely to act
together to reduce birth weight but their independent
effects  are  difficult  to  distinguish  (43).  In  this  study
however,  the  prevalence  of  LBW  was  considerably
higher among women who were anaemic than the non-
anaemic women. In a similar study conducted in Papua
New Guinea to examine the separate contribution of
anaemia  or  malaria  to  low  birthweight  (44),  it  was
observed that there was a trend towards increased low
birthweight  with  decreasing  hemoglobin  levels.
Furthermore,  in  another  related  study  (45),  it  was
showed that there was a positive correlation (r = 0.76; P
= 0.01) between haemoglobin concentration and weight
of the infants at birth  and the mean birth weight of the
infants born to anaemic subjects was significantly lower
compared  to  that  of  infants  born  to  non-anaemic
subjects.  These  previous  observations,  in  addition  to
those of this present study, suggest that anaemia had aMalaria, HIV and Birth Weight 47 Vol. 12  No. 2
significant influence on the birth weight of the infant.
Therefore,  the  treatment  of  anaemia  in  pregnancy  is
most  likely  to  improve  birthweight.  However  in  an
attempt to quantify the separate effects of anemia- and
malaria-attributable low birth weight, Brabin and Piper
(44) concluded that, in malarious areas, malaria was a
more important risk factor for low birth weight than was
anemia.
Interestingly,  the  prevalence  of  LBW  was
considerably  higher  among  the  HIV  positive  women
than the HIV-negative women in this present study. This
is similar to the findings in northern Zimbabwe (13),
where HIV infection was independently associated with
increased risk of low birth weight (OR = 3.16, 95% CI:
1.80-5.54) and very low birth weight (OR = 10.74, 95%
CI: 2.12-54.41). Furthermore, in Kigali, Rwanda, it was
observed  that  the  frequencies  of  low  birthweight,
prematurity,  and  intrauterine  growth  retardation  were
higher in infants born to HIV-positive women than to
HIV  negative  women  (19).  In  yet  another  study
conducted  in  Kigali,  Rwanda,  low  birth  weight  was
significantly more frequent in full-term infants born to
HIV-positive  mothers  than  to  HIV-negative  mothers
(20). These results underscore the need for nutritional
surveillance and dietary counseling, hoping to improve
the  prognosis  of  pregnancy  in  HIV-positive  women,
regardless of other therapeutic interventions.
It was noted in this study that a very high proportion
of LBW occurred among babies born by women who
did not attend the antenatal clinic and the prevalence of
LBW reduced with increase in the number of antenatal
clinic  visits.  This  finding  clearly  demonstrates  the
efficacy  of  antimalaria  chemoprophylaxis  and
haematenics  which  are  usually  administered  during
ANC  in  the  prevention  of  malaria  and  anaemia  and
improvement  of  neonatal  birth  weight.  This  finding
supported earlier reports from The Gambia where the
birth weight of children born to women who received
chemoprophylaxis was increased by an average of 153
g (41). In another related study the administration of
chemoprophylaxis led to a reduction in the prevalence
of low birth weight babies and to an increase in the
median birth weight and the perinatal mortality rate was
lower, although not significantly so, among the babies
of women who had received chemoprophylaxis (46).
Furthermore, in a study in rural Malawi (39), it was
noted  that    the  use  of  an  effective  antimalarial  was
protective against LBW through its effect on reducing
placental and umbilical cord blood malaria infection.
The  study  concluded  that  effective  prevention  of
malaria in pregnant women in malaria-endemic settings
may reduce the likelihood of LBW by 5-14%, and may
reduce the amount of preventable LBW by more than
30%.  Therefore,  when  evaluating  antenatal  care
programs,  health  policy  makers  must  consider
providing an effective preventive drug as a means to
prevent low birth weight and its consequences.
Our inability to assess other possible factors such as
nutritional  deficiency,  hookworm,  urinary
schistosomiasis, tuberculosis, etc which may contribute
to  anaemia  during  pregnancy  in  the  present  study
population, was a major drawback to this investigation.
The  lack  of  any  iron  indicator,  i.e.  ferritin  or  serum
transferrin receptor, is a major limitation of this study.
Another limitation of this study was the failure to obtain
the information on the birth weight of all the babies
born by the 300 mothers from whom blood samples
were obtained. Furthermore, lack of information on the
disease  stage  of  HIV-infected  women  is  yet  another
limitation  to  this  study.  These  limitations  may  have
affected  the  adequate  assessment  of  the  contributory
role of malaria, HIV infection and anaemia on the birth
weight  of  the  babies  assessed.  Future  research
incorporating these aspects is advocated.
In conclusion, in most part of the developing world,
maternal  and  child  health  services  are  the  most
accessible  health  services  in  many  communities.  In
these settings ANC clinics serve as the main entry point
for prevention and care services for pregnant women
and their children. But they also serve as a good link to
other health services for families and communities. In
sub-Saharan  Africa,  antenatal  care  utilization  is
relatively high as more pregnant women are encouraged
to  avail  themselves  with  the  antenatal  care  services
offered.  Delivery  of  malaria  and  HIV  interventions
within  existing  health  services  may  permit  effective
utilization  of  human  resources  and  address  serious
resource  constraints.  The  challenge  is  to  ensure
coherence at each level of the health system, and to
maximize the use of available resources for integrated
service delivery. 
ACKNOWlEDGEMENTS
The authors thank the management of Ebonyi State
University Teaching Hospital for logistic support.
REFERENCES
1. World  Health  Organization  (WHO).    Malaria  and  HIV
interactions  and  their  implications  for  public  health  policy.
Report  of  a  Technical  Consultation  on  Malaria  and  HIV
Interactions and Public Health Policy Implications 2004. World
Health  Organization, Geneva, Switzerland; 2005.
2. Huff B. HIV and malaria: two intertwining epidemics. American
Foundation for AIDS Research;     6: 1–5, 2000.
3. World  Health  Organization.  Expert  Committee  on  Malaria.
WHO  Technical  Report    Series.  892,  i-v.    World  Health
Organization, Geneva, Switzerland; 2000.
4. World  Health  Organization  (WHO)  (1997).  World  malaria
situation  in  1994.  Weekly  Epidemiological    Record  72:
285–290, 1997.48 McGill Journal of Medicine 2009
5. World Health Organization (WHO). The African Malaria Report
2003. World Health Organization, Geneva, Switzerland; 2003. 
6. De  Cock  KM,  Weiss  HA.  The  global  epidemiology  of
HIV/AIDS.  Tropical  Medicine  and  International  Health
5:A3–A9, 2000.  
7. World  Health  Organization  (WHO).  AIDS  epidemic  update.
Geneva, UNAIDS/WHO; 2004.  
8. Dabis F, Ekpini ER. HIV-1/AIDS and maternal and child health
in Africa. Lancet 359:2097–2104, 2002.
9. Regional Office for Africa of the World Health Organization. A
Policy Framework for alaria  Prevention and Control During
Pregnancy  in  the  African  Region,  Final  Draft  December19,
2003. Harare: World Health Organization; 2004
10. UNAIDS. Global HIV/AIDS epidemic update. UNAIDS/World
Health Organization. eneva, Switzerland; 2001. 
11. WHO.  Malaria  and  HIV/AIDS  interactions  and  implications:
conclusions  of  a  technical  consultation  convened  by  WHO,
23–25  June  2004.http://www.who.int/malaria/malaria_HIV/
malaria_hiv_flyer.pdf (accessed March 1, 2007).
12. ter Kuile FO, Parise ME, Verhoeff FH, et al. The burden of co-
infection  with  human  immunoideficiency  virus  type  1  and
malaria  in  pregnant  women  in  sub-Saharan Africa.American
Journal of Tropical Medicine and Hygiene 71: 41-54, 2004.
13. Ticconi C, Mapfumo M, Dorrucci M, et al. Effect of maternal
HIV and malaria infection on pregnancy  and perinatal outcome
in  Zimbnabwe.  Journal  of  Acquired  Immune  Deficiency
Syndrome 34: 289-294, 2003.
14. McCormick MC. The contribution of low birth weight to infant
mortality  and  childhood  mortality.  New    England  Journal  of
Medicine 312: 82–90, 1985.
15. Guyatt H L, Snow RW. Malaria in pregnancy as an indirect
cause of infant mortality in sub-Saharan Africa. Transactions of
the Royal Society of Tropical Medicine and Hygiene 95:569–
576, 2001.
16. Mangochi  Malaria  Research  Project.  Malaria  prevention  in
pregnancy:  the  effects  of  treatment  nd  chemoprophylaxis  on
placental malaria infection, low birth weight, and fetal, infant,
and child survival. U.S. Agency for International Development
in conjunction with Centers for Disease Control and Prevention,
Atlanta, Ga; 1993.
17. Kasumba IN, Nalunkuma AJ, Mujuzi G, et al.  Low birthweight
associated with maternal anaemia and Plasmodium falciparum
infection during pregnancy, in a peri-urban/urban area of low
endemicity  in  Uganda.  Annals  of    Tropical  Medicine  and
Parasitology  94: 7–13, 2000.
18. Okoko BJ, Ota MO, Yamuah LK, et al. Influence of placental
malaria infection on foetal outcome in the Gambia: twenty years
after Ian McGregor. Journal of  Health Population and Nutrition
20: 4–11, 2002.
19. Castetbon  K,  Ladner  J,  Leroy  V,  et  al.  Low  birthweight  in
infants born to African HIV-infected women: relationship with
maternal body weight during pregnancy: Pregnancy and HIV
Study Group (EGE). Journal of Tropical Pediatrics 45(3):152-
157,1999.
20. Leroy  V,  Ladner  J,  Nyiraziraje  M,  et  al.  Effect  of  HIV-1
infection on pregnancy outcome in women in Kigali, Rwanda,
1992-1994. Pregnancy and HIV Study Group. AIDS 12:643-
650,1998.
21. Dreyfuss ML, Msamanga GI, Spiegelman D, Hunter DJ, Urassa
EJ, Hertzmark E, Fawzi WW. Determinants of low birth weight
among  HIV-infected  pregnant  women  in Tanzania. American
Journal of Clinical Nutrition 74 :814-826, 2001.
22. World  Medical  Association  Declaration  of  Helsinki.  Ethical
principles for medical research involving human subjects. World
Medical  Association,  2000.  Available  at
http://www.wma.net/e/policy/b3.htm. Accessed June 15, 2005.
23. World Health Organization (WHO). Basic  Malaria Microscopy.
Learner’s Guide. Geneva,  WHO; 1991.
24. Dacie,  JV,  Lewis,  SM.  Practical  Haematology.  8  th  edition.
Edinburgh, Churchill  Livingstone,  1994.
25. Mockenhaupt  FP,  Bedu-Addo  G,  von  Gaertner  C,  et  al.
Detection  and  clinical  manifestation  of  placental  malaria  in
southern Ghana.  Malaria  Journal 5:119, 2006.
26. Matteelli A, Donato F, Shein A, et al. Malarial infection and
birthweight  in  urban  Zanzibar,  Tanzania. Annals  of  Tropical
Medicine and Parasitology. 90:125-134, 1996.
27. Bergstrom S, Fernandes A, Schwalbach J, et al.  Materno-fetal
transmission of pregnancy malaria: an immunoparasitological
study on 202 parturients in Maputo. Gynecologic and Obstetrics
Investigations 35:103-107, 1993.
28. Adam I, Khamis AH, Elbashir MI. Prevalence and risk factors
for  Plasmodium  falciparum  malaria  in  pregnant  women  of
eastern Sudan. Malaria Journal  4:18, 2005.
29. Lander J, Leroy V, Simonon A, et al. HIV infection, malaria, and
pregnancy: a prospective cohort study in Kigali, Rwanda. American
Journal of  Tropical Medicine and Hygiene 66:56-60, 2002.
30. Bouyou-Akotet  MK,  Ionete-Collard  DE,  Mabika-Manfoumbi
M, et al. Prevalence of  Plasmodium falciparum infection in
pregnant women in Gabon. Malaria Journal 2:18, 2003.
31. Rogerson SJ, Van den Broek NR, et al. Malaria and anemia in
antenatal women in Blantyre, Malawi: a twelve-month survey.
American Journal of  Tropical Medicine and   Hygiene  62:335-
40, 2000.
32. Mockenhaupt  FP,  Rong  B,  Gunther  M,  et  al.  Anaemia  in
pregnant  Ghanaian  women:  importance  of  malaria,  iron
deficiency and haemoglobinopathies Transactions of the Royal
Society of Tropical Medicine and Hygiene  94:477-483, 2000.
33. Steketee RW, Wirima JJ, Bloland PB, et al. Impairment of a
pregnant  woman’s  acquired  ability  to  limit  Plasmodium
falciparum  by  infection  with  human  immunodeficiency  virus
type-1. American Journal of  Tropical Medicine and   Hygiene
55: 42-49, 1996.
34. van Eijk AM, Ayisi JG, ter Kuile FO, et al. HIV increases the
risk of malaria in women of all gravidities in Kisumu, Kenya.
AIDS 17:595-603, 2003.
35. Wabwire-Mangen F, Shiff CJ, Vlahov D, et al.. Immunological
effects of HIV-1 infection on the  humoral response to malaria
in  an  African  population.  American  Journal  of  Tropical
Medicine and   Hygiene   41:504-511, 1989.
36. Parise  ME,  Lewis  LS,  Ayisi  JG,  et  al.  A  rapid  assessment
approach  for  public  health  decision-  making  related  to  the
prevention of malaria during pregnancy. Bulletin of the World
Health Organization 81:316-23, 2003.
37. Miaffo  C,  Some  F,  Kouyate  B,  et  al.  .Malaria  and  anemia
prevention  in  pregnant  women  of  rural  Burkina  Faso.  BMC
Pregnancy Childbirth 4:18, 2004.
38. Steketee,  RW;  Nahlen,  BL;  Parise,  ME;  Menendez,  C.  The
burden  of  malaria  in  pregnancy  in  malaria-endemic  areas.
American  Journal  of    Tropical    Medicine  and      Hygiene
64:28–35, 2001.
39. Steketee RW, Wirima JJ, Hightower AW, et al. The effect of
malaria  and  malaria  prevention  in  pregnancy  on  offspring
birthweight, prematurity, and intrauterine growth retardation in
rural  Malawi.  American  Journal  of  Tropical  Medicine  and
Hygiene 55:33-41, 1996.
40. Brabin BJ. The risks and severity of malaria in pregnant women.
In: Applied field in malaria reports, no. 1. Geneva, Switzerland:
World Health Organization, (TDR/FIELD-MAL/1), 1991. 
41. Menendez  C,  Todd  J,  Alonso  PL,  et  al.  Malaria
chemoprophylaxis, infection of the placenta and birthweight in
Gambian  primigravidae.  Journal  of  Tropical  Medicine  and
Hygiene 97:244–248, 1994.Malaria, HIV and Birth Weight 49 Vol. 12  No. 2
42. Cot M, Le Hesran JY, Miailhes P, et al. Increase of birth weight
following  chloroquine  chemoprophylaxis  during  the  first
pregnancy: results of a randomised trial in Cameroon. American
Journal of  Tropical  Medicine and Hygiene   53:581–585, 1995.
43. Shulman  CE,  Marshall  T,  Dorman  EK,  et  al.    Malaria  in
pregnancy:  adverse  effects  on  haemoglobin  levels  and
birthweight  in  primigravidae  and  multigravidae.  Tropical
Medicine and International Health 6:770-778, 2001.
44. Brabin  B,  Piper  C.  Anaemia-  and  malaria-attributable  low
birthweight in two populations in Papua New Guinea. Annals of
Human Biology 24:547-555, 1997.
45. Msolla  MJ,  Kinabo  JL.  Prevalence  of  anaemia  in  pregnant
women during the last trimester. International Journal of Food
Science and Nutrition 48:265-270, 1997.
46. Greenwood AM, Menendez C, Todd J,et al. The distribution of
birth  weights  in  Gambian  women  who  received  malaria
chemoprophylaxis during their first pregnancy and in control
women. Transactions of the Royal Society of Tropical Medicine
and Hygiene  88:311-312, 1994.
Chigozie Jesse Uneke is a medical parasitologist and is investigating the impact and public health implications
of major parasitic diseases in high risk populations in Nigeria. This study was part of requirement for the award
of PhD to him by the University of Jos Nigeria. 
Treasure N. Ujam has concluded her BSc program from Ebonyi State University and is commencing a post
graduate program leading to the award of MSc in same institution. 
Dotchka D. Duhlinska is a professor of  parasitology. She has supervised a number of PhD research projects
in the University of Jos Nigeria including this study. 